Medicine Supply Notification: Ramipril 1.25mg capsules
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 1.25mg capsules.
MSN/2026/022
Tier 2 – Medium impact
Date of issue: 23 April 2026
- There are intermittent supply issues with ramipril 1.25mg capsules until the end of May 2026.
- Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available but cannot support increased demand.
- A Serious Shortage Protocol (SSP) for ramipril 1.25mg capsules was issued on 22/04/2026 which allows community pharmacists to limit supply to one month.
- Other low dose formulations of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) remain available, some of which can support increased demand (see Supporting information)
A copy of this medicine supply notification, including supporting information, has been sent to all pharmacy NHS email addresses.
DHSC and NHS England have launched an online Medicines Supply Tool, which provides up-to-date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
